Lung cancer is the leading cause of cancer deaths among men and women in the United States. For women, it accounts for more deaths than breast, ovarian, and uterine cancer combined. Consequently, medical researchers have been working hard to increase our understanding of lung cancer and help us better prevent, diagnose, and treat the condition.
Posted by Brigham and Women's Hospital November 13, 2014
Posted by Brigham and Women's Hospital November 5, 2014
Lung cancer, the most frequent cause of cancer death in this country and around the world, continues to be an important public health epidemic. The American Cancer Society projects that by the end of this year alone, there will have been 224,000 new cases of lung cancer diagnosed in the U.S., and 159,000 Americans will have died from the disease.
Most, but not all, cases of lung cancer are attributable to smoking. Thus, the most important thing that people can do to reduce their risk of developing lung cancer is to quit smoking, or better yet, never start.
For current or former long-term smokers, lung cancer screening should be a priority. Research has shown that new screening guidelines for the use of low-dose computed tomography (CT) should significantly reduce the number of deaths from lung cancer by improving early detection. In the following video, thoracic radiologist Dr. Francine Jacobson provides more details about the benefits of low-dose CT scans and who should get screened.
Posted by Brigham and Women's Hospital November 4, 2014
The Advanced Multimodality Image Guided Operating (AMIGO) suite at Brigham and Women’s Hospital is a state-of-the-art medical and surgical research environment that houses a vast array of advanced imaging equipment and interventional (minimally invasive) surgical systems. Multidisciplinary teams of specialists use the suite’s advanced technology and unique design to efficiently and precisely guide treatment — before, during, and after surgery — without the patient or medical team ever leaving the operating room.
The AMIGO suite gives physician-researchers an optimized setting for innovatively merging imaging and surgery to improve standard clinical procedures and to develop new therapeutic approaches. With the primary goal of improving the effectiveness of patient care, success already has been demonstrated in several treatment areas, including: image-guided therapy in open brain surgery, radiation treatment of prostate cancer and gynecological tumors, breast-conserving therapy, MRI-guided cryoablation (destroying diseased tissue via extreme cold), treatment of atrial and ventricular fibrillation, and brain tumor laser ablation (destroying diseased tissue with focused heat). In the following video, Dr. Steven Seltzer, Chair of the Department of Radiology at Brigham and Women’s Hospital (BWH) and Dr. Michael Zinner, Chair of the BWH Department of Surgery, offer an inside look at the AMIGO suite and detail its potential for improving the effectiveness of image-guided therapy.
Posted by Brigham and Women's Hospital October 29, 2014
Cancer experts from Brigham and Women’s Hospital and Dana-Farber Cancer Institute (DFCI) work together to provide cancer patients the latest therapies, including access to innovative clinical trials through Dana-Farber/Brigham and Women’s Cancer Center. Today’s post originally appeared on Insight, the blog of DFCI.
While the majority of women diagnosed with breast cancer are age 55 or older, about 14,500 women age 45 and younger are diagnosed with breast cancer in the U.S. each year. Here are some facts about breast cancer all young women should know.
Posted by Brigham and Women's Hospital October 14, 2014
Prostate cancer is the second most common and deadly cancer among American men. About 1 in 6 men will be diagnosed with prostate cancer during their lifetime, and about 1 in 33 men will die from the disease. Yet, despite the disease’s potential dangers, many men diagnosed with prostate cancer shouldn’t be treated aggressively, and others shouldn’t be treated at all (but still be closely monitored). This is why Dr. Anthony D’Amico, Chief of the Prostate Cancer Radiation Oncology Service at Dana-Farber/Brigham and Women’s Cancer Center, says that determining a prostate cancer patient’s risk level is critical to determining their treatment. Watch the video below to learn more.
Posted by Brigham and Women's Hospital October 2, 2014
Currently, up to 40 percent of patients undergoing breast-conserving surgery to treat cancer require re-operation because of a failure to remove all of the cancerous tissue during the initial operation. Brigham and Women’s Hospital (BWH) researchers, however, have successfully tested an innovative tissue imaging approach that accurately distinguishes cancerous breast tissue from normal breast tissue and precisely defines the margins between the two – an advance that could significantly decrease the need for follow-up surgery.
The tool the researchers used for their study is called desorption electrospray ionization (DESI) mass spectrometry imaging, a technology that allows physicians and researchers to promptly evaluate human tissue. It works by electrically charging (ionizing) molecules in a tissue sample through the application of a microscopic stream of solvent. The mass of these ionized molecules is then measured and their distribution within the tissue is mapped.
Posted by Brigham and Women's Hospital September 9, 2014
The Center for Neuro-Oncology at Dana-Farber/Brigham and Women’s Cancer Center brings together cancer experts from Brigham and Women’s Hospital and Dana-Farber Cancer Institute to offer state-of the-art treatment for patients with brain tumors, spinal cord tumors, and neurologic complications from cancer. Today’s post originally appeared on Insight, the blog of Dana-Farber Cancer Institute.
Glioblastomas are the most common primary cancer of the brain. Although it is a fast-moving cancer, doctors know a lot about this type of tumor and are finding ways to fight it.
Here are five things you need to know about glioblastomas:
Posted by Brigham and Women's Hospital July 31, 2014
For the twenty-second year in a row, Brigham and Women’s Hospital (BWH) has been named to the U.S. News & World Report’s Honor Roll of America’s Best Hospitals, ranking ninth. The Honor Roll highlights just 17 hospitals, out of nearly 5,000 nationwide, for their breadth and depth of clinical excellence.
We’ve gathered a few recent blog posts in our top ranked clinical categories to recognize the dedication and accomplishments of our doctors, nurses, researchers, and other members of our clinical teams.
Posted by Brigham and Women's Hospital July 23, 2014
Cancer experts from Brigham and Women’s Hospital and Dana-Farber Cancer Institute work together to provide cancer patients the latest therapies, including access to innovative clinical trials through Brigham and Women’s/Dana-Farber Cancer Center. Today’s post originally appeared on Insight, the blog of Dana-Farber Cancer Institute.
There’s a broad range of news and information about breast cancer online. That creates wonderful opportunities to learn about prevention, treatment, cures, and recurrence. But it also means you may run into confusing misinformation and oversimplifications.
Here are some popular misconceptions:
Most breast cancer is hereditary. While it’s true that a woman’s risk factor for developing breast cancer doubles if a first-degree relative has the disease, this statistic doesn’t tell the whole story.
Posted by Brigham and Women's Hospital June 30, 2014
For many patients with brain tumors or other abnormal tissue located deep in the brain, treatment options have been limited. Last year, Jill Colter, now 50, discovered that a brain tumor resulting from Stage IV melanoma had returned. “Several years earlier, I had treatment with surgery and radiation, but the tumor came back,” Jill says. Due to the location of Jill’s tumor and her prior radiation, surgery and further radiation weren’t possible to treat her tumor.
Jill was referred to neurosurgeon Alexandra Golby, MD, Director of Image-guided Neurosurgery and Clinical Co-director of the Advanced Multimodality Image Guided Operating (AMIGO) Suite at Brigham and Women’s Hospital and a key member of the Center for Neuro-Oncology team at Dana-Farber/Brigham and Women’s Cancer Center.